Page last updated: 2024-10-27

fenoldopam and Medulloblastoma

fenoldopam has been researched along with Medulloblastoma in 1 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research Excerpts

ExcerptRelevanceReference
"Fenoldopam is a direct-acting vasodilator that acts at the postsynaptic dopamine 1 receptors in renal, coronary, cerebral, and splanchnic vasculature resulting in arterial dilation and a lowering of the mean arterial pressure (MAP)."2.40Initial experience with fenoldopam in children. ( Pruitt, RD; Strauser, LM; Tobias, JD, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strauser, LM1
Pruitt, RD1
Tobias, JD1

Reviews

1 review available for fenoldopam and Medulloblastoma

ArticleYear
Initial experience with fenoldopam in children.
    American journal of therapeutics, 1999, Volume: 6, Issue:5

    Topics: Age Factors; Antihypertensive Agents; Body Weight; Brain Neoplasms; Child; Dopamine Agonists; Emerge

1999